Rat teratogenicity studies of cilostazol showed an increased number of abnormal fetuses, low birth weight and an increased number of stillborn. The drug should not be used in women who are pregnant or may possibly become pregnant.
Rat studies showed that cilostazol is distributed into breast milk in nursing rats. Nursing should be interrupted when the drug is administered to nursing women.